Supernus Pharmaceuticals, Inc. (SUPN)
46.51
+0.35
(+0.76%)
USD |
NASDAQ |
Dec 11, 16:00
46.50
-0.02
(-0.03%)
After-Hours: 20:00
Supernus Pharmaceuticals Research and Development Expense (% of Annual Revenues)
Research and Development Expense (% of Annual Revenues) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (% of Annual Revenues) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median